Literature DB >> 9844043

C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish.

A M O'Hara1, B A Fernie, A P Moran, Y E Williams, J J Connaughton, A Orren, M J Hobart.   

Abstract

Human deficiencies of terminal complement components are known to be associated with increased susceptibility to Neisseria meningitidis infection. Polymorphic DNA marker studies in complement deficient investigations allow identification of haplotypes associated with the deficiency and enable the possible identification of heterozygote carriers of the defect. We report studies of an Irish family in which the index case had suffered recurrent meningococcal disease and was found to be deficient in the seventh component of complement (C7). The availability of all family members enabled us to determine the segregating haplotypes. The defects in the family segregated with two very closely related C6 and C7 DNA haplotypes, one of which is known to be associated with the large Irish C7 DNA deletion defect. The index case and two C7 deficient siblings were found to be homozygous for this defect, a deletion that spans approx. 6.8 kbp and encompasses exons 7 and 8. The deletion defect of exons 7 and 8 of C7 has been found in homozygous form in another C7 deficient Irish individual, and is present in heterozygous form in C7 deficient members of a third Irish family. Therefore, this deletion defect occurs in five of the six deficient chromosomes of these three unrelated Irish families, raising the interesting question of how prevalent this defect may be within the Irish community.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844043      PMCID: PMC1905122          DOI: 10.1046/j.1365-2249.1998.00737.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  A novel protein polymorphism of human complement C7 detected by a monoclonal antibody.

Authors:  R Würzner; M J Hobart; A Orren; K Tokunaga; R Nitze; O Götze; P J Lachmann
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  TaqI polymorphism in the complement component C7 gene.

Authors:  E Coto; E Martinez-Naves; O Dominguez; J M Urra; V Rodriguez; C López-Larrea
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

3.  Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.

Authors:  P C Potter; C E Frasch; W J van der Sande; R C Cooper; Y Patel; A Orren
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

4.  Correlation of a Glu/Ala substitution at position 98 with the complement C6 A/B phenotypes.

Authors:  B A Fernie; G Delbridge; M J Hobart
Journal:  Hum Mol Genet       Date:  1993-05       Impact factor: 6.150

5.  A physical map of the human complement component C6, C7, and C9 genes.

Authors:  F Setién; V Alvarez; E Coto; R G DiScipio; C López-Larrea
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  A physical map of the C6 and C7 complement component gene region on chromosome 5p13.

Authors:  M J Hobart; B A Fernie; R G DiScipio; P J Lachmann
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

7.  Polymorphism of human complement component C6: an amino acid substitution (Glu/Ala) within the second thrombospondin repeat differentiates between the two common allotypes C6 A and C6 B.

Authors:  G Dewald; M M Nöthen; S Cichon
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

Review 8.  Inherited deficiencies of the terminal components of human complement.

Authors:  R Würzner; A Orren; P J Lachmann
Journal:  Immunodefic Rev       Date:  1992

9.  DNA polymorphisms and linkage relationship of the human complement component C6, C7, and C9 genes.

Authors:  E Coto; E Martínez-Naves; O Domínguez; R G DiScipio; J M Urra; C López-Larrea
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

10.  Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping.

Authors:  L J Egan; A Orren; J Doherty; R Würzner; C F McCarthy
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

View more
  7 in total

Review 1.  Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.

Authors:  A Orren
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.

Authors:  Ann Orren; Ann M O'Hara; B Paul Morgan; Anthony P Moran; Reinhard Würzner
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

3.  Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.

Authors:  A M O'Hara; A P Moran; R Würzner; A Orren
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

Review 4.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Complement component C7 deficiency in two Spanish families.

Authors:  Sonia Barroso; Berta Sánchez; Antonia José Alvarez; Margarita López-Trascasa; Amparo Lanuza; Rafael Luque; Ingeborg Wichmann; Antonio Núñez-Roldán
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

6.  Complement component C7 deficiency in a Spanish family.

Authors:  M F Vázquez-Bermúdez; S Barroso; K Walter; A J Alvarez; A Alarcón; M López-Trascasa; I Wichmann; F Aguilar; A Núñez-Roldán; B Sánchez
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

7.  Two mutations of the C7 gene, c.1424G > A and c.281-1G > T, in two Korean families.

Authors:  Hee Jung Kang; Chang-Seok Ki; Yeon-Sook Kim; Mina Hur; So Ick Jang; Ki Sik Min
Journal:  J Clin Immunol       Date:  2006-03-22       Impact factor: 8.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.